Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
15.50
-0.35 (-2.21%)
Jun 9, 2026, 3:04 PM CST
SHE:000739 Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, SHE:000739 stock has a consensus rating of "Strong Buy" and an average price target of ¥20.07. The average 1-year stock price forecast is 29.48% higher than the current stock price, while the lowest is ¥19.00 (+22.58%) and the highest is ¥21.00 (+35.48%).
Price Target: ¥20.07 (+29.48%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHE:000739 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 4 | 5 | 5 |
Financial Forecast
Revenue This Year
10.45B
from 9.78B
Increased by 6.78%
Revenue Next Year
11.34B
from 10.45B
Increased by 8.60%
EPS This Year
0.89
from 0.67
Increased by 33.43%
EPS Next Year
1.03
from 0.89
Increased by 15.73%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.0B | ||
| Avg | 10.4B | ||
| Low | 9.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.0% | ||
| Avg | 6.8% | ||
| Low | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 0.89 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 33.4% | ||
| Low | - |